Evidence map›Paper›PMID 40708167›Full record

ArticleGlia2025

Hypothalamic Astrocytes Exhibit Glycolytic Features Making Them Prone for Glucose Sensing.

Sarah Geller, Nadège Zanou, Sylviane Lagarrigue, Tamara Zehnder, Cathy Gouelle, Tania Santoro, Cendrine Repond, Paola Bezzi, Francesca Amati, Anne-Karine Bouzier-Sore and 2 more

Abstract read
In one paragraph

Article in Glia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sarah GellerDepartment of Physiology, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-3685-4521
Nadège ZanouInstitute of Sports Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-6626-3127
Sylviane LagarrigueDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-0553-1818
Tamara ZehnderDepartment of Fundamental Neuroscience, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-2522-8998
Cathy GouelleDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0009-0003-6833-0209
Tania SantoroDepartment of Physiology, University of Lausanne, Lausanne, Switzerland.
Cendrine RepondDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-7570-676X
Paola BezziDepartment of Fundamental Neuroscience, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-8279-3600
Francesca AmatiDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-1731-0262
Anne-Karine Bouzier-SoreCentre de Résonance Magnétique Des Systèmes Biologiques, UMR5536 CNRS, Université de Bordeaux, CNRS, Bordeaux, France.ORCID 0000-0002-3470-0940
Ariane SharifLaboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, FHU 1000 Days for Health, University of Lille (Univ. Lille), Inserm, CHU Lille, Lille, France.ORCID 0000-0003-0810-400X
Luc PellerinDepartment of Physiology, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-1016-1970

Funding

Institut National de la Santé et de la Recherche MédicaleSwiss National Science Foundation 140957Swiss National Science Foundation 141960Swiss National Science Foundation 170062Swiss National Science Foundation 185363Université de Bordeaux ANR-10-IDEX-03-02Université de LausanneUniversité de Lille
6 · The paper itself

Abstract

In the hypothalamus, detection of energy substrates such as glucose is essential to regulate food intake and peripheral energy homeostasis. Metabolic interactions between astrocytes and neurons via lactate exchange have been proposed as a hypothalamic glucose-sensing mechanism, but the molecular basis remains uncertain. Mouse hypothalamic astrocytes in vitro were found to exhibit a stronger glycolytic phenotype in basal conditions than cortical astrocytes. It was associated with higher protein expression levels of the Pyruvate Kinase Isoform M2 (Pkm2) and its more prominent nuclear localization. In parallel, hypothalamic astrocytes also expressed higher levels of the monocarboxylate transporter Slc16a3 (Mct4), which were dependent on Pkm2 expression. The stronger Mct4 expression in hypothalamic versus cortical astrocytes is an intrinsic characteristic, as it was also present after their direct isolation from adult mouse tissue. The high lactate release capacity of hypothalamic astrocytes was demonstrated to depend on the expression of Mct4, but not Mct1. Unlike cortical astrocytes, hypothalamic astrocytes in culture do not respond to glutamate with enhanced glycolysis, but instead, they modulate their lactate production according to glucose concentrations in an AMPK-dependent manner, an effect observed in both mouse and human hypothalamic astrocytes in vitro. Our study shows that hypothalamic and cortical astrocytes are geared to have distinct glycolytic responses to glucose and glutamate, respectively. These results reveal a metabolic specialization of astrocytes in order to fulfill distinct area-specific functions: glucose-sensing in the hypothalamus versus activity-dependent neuronal energetic supply in cortical regions.

Indexed as

AstrocytesGlucoseGlycolysisHypothalamusAnimalsCells, CulturedCerebral CortexHumansLactic AcidMaleMiceMice, Inbred C57BLMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersMuscle ProteinsPyruvate KinaseGlucoseLactic AcidMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersMuscle ProteinsPyruvate KinaseSlc16a4 protein, mouseSymportersastrocytesglucosehypothalamuslactateMct1Mct4Pkm2

Identifiers

PMID40708167
PMCPMC12436996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.